Le cancer
Innovations médicales
Publications
Faire un don
Projets primés 2024
Projets primés en 2024
1-T cell targeting chimeric antigen receptor (CAR) regulatory T cells (Tregs) for graft-versus-host-disease (GvHD) prevention
Chiara Bernardi
2-153sm-fapi-46 radioligand therapy with high-molar activity 153s
CERN, Thierry Sora
3-Counteracting Progression Mechanisms to Overcome Immune Checkpoint Inhibitor Resistance in Bladder Cancer
Hajar El Ahanidi
4-Investigating the significance of a novel definition of tumora-associated macrophage polarization as an estimator of the tumor microenvironment state and prognostic tool in pancreatic ductal adenocarcinoma (PDAC)
Marc Pfefferlé.
5-POU5F1B, tumor microenvironment and colorectal cancer metastasis
Laia Simo Riudalbas
6-Personalized ultrahigh field MRI for prostate cancer
Jean-Paul Vallée
7-Investigating PD-L1 expression as predictor of response to neo-adjuvant chemotherapy in locally advanced, hormone receptor positive, HER2 negative breast cancer
Anita Wolfer
MD-PhD Project
Natural Language Processing Framework for Oncology Reports
Johann Pignat.
Projets primés 2023
Projets primés en 2023
- S100A4 in atherosclerosis: from smooth muscle cell to immune regulation
Dr Pascal Azar, Department of Pathology and Immunology UNIGE - Is androgen deprivation therapy associated with increased risk of Alzeimer’s disease and neurodegeneration
Dr Kelly Ceyzeriat, HUG Biomedical Imaging Center - Impact of nociceptors on tumor-associated lymph vessels
Dr Laure Garnier, Department of Pathology and Immunology UNIGE - Molecular and functional interactions between circadian clocks and mRNA degradation in pancreatic islet cells in the context of diabetes
Dr Georgia Katsioudi, Department of Surgery UNIGE - Clinical relevance of fundamental findings in prostate cancer
Dr Julie Terzic, HUG Oncology Department, UNIGE Department of Medicine